Improving HIV Prevention Among Heterosexual Men Seeking STI Services in Malawi
NCT ID: NCT06200545
Last Updated: 2025-12-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
199 participants
INTERVENTIONAL
2024-04-02
2025-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe
NCT05307991
Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities
NCT03823209
Evaluation of Pre-Exposure Prophylaxis for High Risk Adolescent Girls and Young Women
NCT04044235
Church-based HIV Screening: Taking It to the Pews
NCT02529644
Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP"
NCT05528653
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of care PrEP services
Standard of care (SOC) PrEP services include PrEP eligibility assessment, rapid HIV antibody testing prior to provision and/or refill of PrEP, and PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines. Specifically, SOC services do not generally include point of contact STI testing (with the exception of rapid syphilis and Hepatitis B antigen testing, if kits are available, at PrEP initiation) nor tracing for missed PrEP visits. Participants randomized to the SOC condition will receive these standard PrEP services.
PrEP eligibility assessment
PrEP eligibility assessment
Rapid HIV antibody testing prior to provision and/or refill of PrEP
Rapid HIV antibody testing prior to provision and/or refill of PrEP
PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines
PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines
Intervention package PrEP services
The intervention package is integrated into PrEP visits and includes evaluation of barriers and facilitators to ongoing PrEP use, point of contact STI testing to inform counseling regarding ongoing PrEP care engagement, tracing for any missed PrEP visits, and offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period. Recognizing increasingly cyclical PrEP use patterns, navigators serve as a direct entry point to retain or re-engage participants in HIV prevention care.
PrEP eligibility assessment
PrEP eligibility assessment
Rapid HIV antibody testing prior to provision and/or refill of PrEP
Rapid HIV antibody testing prior to provision and/or refill of PrEP
PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines
PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines
Evaluation of barriers and facilitators to ongoing PrEP use
Evaluation of barriers and facilitators to ongoing PrEP use
Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement
Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement
Tracing for any missed PrEP visits
Tracing for any missed PrEP visits
Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period
Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PrEP eligibility assessment
PrEP eligibility assessment
Rapid HIV antibody testing prior to provision and/or refill of PrEP
Rapid HIV antibody testing prior to provision and/or refill of PrEP
PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines
PrEP follow-up with a PrEP nurse in accordance with contemporary PrEP guidelines
Evaluation of barriers and facilitators to ongoing PrEP use
Evaluation of barriers and facilitators to ongoing PrEP use
Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement
Point of contact STI testing to inform counseling regarding ongoing PrEP care engagement
Tracing for any missed PrEP visits
Tracing for any missed PrEP visits
Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period
Offering a PrEP "restart" kit for men who choose to discontinue PrEP during the follow-up period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years, or age 15-17 (with assent and parent/guardian consent)
* Able to provide informed consent
* No plans to move outside study area for at least 26 weeks after study enrollment
* Willing to provide contact/locator information, including phone number, to facilitate tracing
* Willing to participate in study activities, including specimen collection
* Willing to participate in study activities, including systems navigation, counseling, and point of contact STI testing
* Sought STI clinic services within 7 days of enrollment
* Initiated on PrEP at STI clinic within 7 days of enrollment
* Reports at least one female sex partner in the 6 months prior to enrollment
* Self-identifies as heterosexual
2. Individuals who meet all of the following criteria are eligible for inclusion in this study as other key stakeholders:
* Age ≥18 years at the enrollment visit
* Able to provide informed consent
* Involved in provision of clinical service navigation, systems navigation, STI or HIV care or prevention (including clinic management or oversight), or development of HIV prevention policy or programs at local or national level
Exclusion Criteria
* Appearance of psychological disturbance or cognitive impairment that would limit the ability to understand study procedures, as determined by the investigators
* Any other condition that, in the opinion of the investigators, would make participation in the study unsafe, or otherwise interfere with the conduct of the study
* Current participation in any HIV prevention study or other study considered to interfere the interpretation of study outcomes.
2. Individuals who meet any of the following criteria are ineligible for inclusion in this study as other key stakeholder:
* Appearance of psychological disturbance or cognitive impairment that would limit the ability to understand study procedures, as determined by the investigators
* Any other condition that, in the opinion of the investigators, would make participation in the study unsafe, or otherwise interfere with the study activities
15 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HIV Prevention Trials Network
NETWORK
Division of AIDS, US National Institute of Allergy and Infectious Diseases
UNKNOWN
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sarah Rutstein, MD, PhD
Role: STUDY_CHAIR
University of North Carolina, Chapel Hill
Mitch Matoga, MBBS, MSc
Role: STUDY_CHAIR
UNC Project Malawi
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Malawi CRS
Lilongwe, , Malawi
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rutstein SE, Limarzi-Klyn L, Chen JS, Agyei YO, Ahmed S, Bell I, Cohen M, Fogel JM, Go V, Haines D, Hamilton EL, Hoffman IF, Hosseinipour MC, Marzinke MA, Miller WC, Mukatipa M, Pulerwitz J, Spiegel HML, Ye T, Matoga M. Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator-Delivered Integrated Prevention Package (HPTN 112-NJIRA Study). JMIR Res Protoc. 2025 Jun 18;14:e72981. doi: 10.2196/72981.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HPTN 112
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.